Vemedia Revenue and Competitors
Estimated Revenue & Valuation
- Vemedia's estimated annual revenue is currently $38.2M per year.
- Vemedia's estimated revenue per employee is $201,000
Employee Data
- Vemedia has 190 Employees.
- Vemedia grew their employee count by -5% last year.
Vemedia's People
| Name | Title | Email/Phone |
|---|
Vemedia Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $46.2M | 230 | 5% | N/A | N/A |
#2 | $43.8M | 218 | 21% | N/A | N/A |
#3 | $57.1M | 284 | 26% | N/A | N/A |
#4 | $24.5M | 122 | 3% | N/A | N/A |
#5 | $52.9M | 263 | 13% | N/A | N/A |
#6 | $24.7M | 123 | 13% | N/A | N/A |
#7 | $1.8M | 18 | 0% | $114.3M | N/A |
#8 | $7.2M | 36 | -20% | N/A | N/A |
#9 | $13.7M | 68 | -7% | N/A | N/A |
#10 | $7.6M | 39 | -13% | $123.9M | N/A |
What Is Vemedia?
Vemedia BV in Diemen produceert en distribueert al meer dan 70 jaar medische spécialités, farmaceutische producten en voedingssupplementen. Wij zijn een groeiend farmaceutisch bedrijf met gezamenlijk meer dan 150 medewerkers.
keywords:N/A
N/A
Total Funding
190
Number of Employees
$38.2M
Revenue (est)
-5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Vemedia News
... Perrigo, Procter&Gamble Health, Reckitt Benckiser Healthcare, Sanofi, Upsa, Uriach Consumer Healthcare, Vemedia, Viatris y Zambon.
... Lifes2good Holdings Limited, Murad UK Ltd, Vitabiotics Ltd, Reserveage LLC, Amway Corporation, BeautyScoop, Vemedia Pharma N.V..
Switzerland's Laboratoires Diepharmex has been snapped up by Cooper-Vemedia, the pan-European consumer healthcare group backed by ...
PA) has agreed to sell a portfolio of 12 pharmaceutical brands to Charterhouse Capital Partners' Cooper-Vemedia drugs manufacturing arm for ...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $60.6M | 190 | 8% | N/A |
#2 | $52.3M | 190 | -20% | N/A |
#3 | $15M | 190 | 4% | N/A |
#4 | $68.6M | 190 | 14% | N/A |
#5 | $60.6M | 190 | 3% | N/A |